Skip to main content
Clinical Trials/NL-OMON24403
NL-OMON24403
Not yet recruiting
Not Applicable

Cognitive Behavior Therapy for tinnitus related insomnia: a single-case experiment

Maastricht University Faculty of Psychology and Neuroscience0 sites6 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Maastricht University Faculty of Psychology and Neuroscience
Enrollment
6
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Maastricht University Faculty of Psychology and Neuroscience

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • \- Be primarily seeking treatment/help for difficulties caused by tinnitus.
  • \- Additionally complaints of sleep disturbance (e.g. insomnia) as measured by the Insomnia Severity Index.
  • \- Recommended to start CBTi protocol.
  • \- Be at least 18 years of age. \- Have at least moderate tinnitus (as defined by the Tinnitus Questionnaire)

Exclusion Criteria

  • \- Any person who discloses current suicidal intent.
  • \- Severe anxiety or depression (as measured by the HADS\-A and/or HADS\-D.)
  • \- Pregnancy of potential participant or partner.
  • \- Currently undergoing any treatment for tinnitus (e.g. Tinnitus Retraining Therapy).
  • \- Reported to have commenced or ceased a course of antidepressants \[i.e. selective serotonin re\-uptake inhibitors (SSRIs); selective serotonin and norepinephrine re\-uptake inhibitors (SNRIs); atypical antidepressants, tricyclic antidepressants, or monoamine oxidase inhibitors], antipsychotics \[Aripiprazole (Abilify), Asenapine (Saphris), Brexpiprazole (Rexulti), Cariprazine (Vraylar), Clozapine (Clozaril), Iloperidone (Fanapt), Lurasidone (Latuda), Olanzapine (Zyprexa), Paliperidone (Invega), Quetiapine (Seroquel), Risperidone (Risperdal), Ziprasidone (Geodon), Haloperidol], anxioltytics \[beta blockers, benzodiazepines], Ritalin, hormone replacement therapy, or medication to lower high blood pressure (i.e. thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers, beta blockers, calcium channel blockers, renin inhibitors] within the previous 3 months
  • \- Unable to read and write fluently in Dutch.

Outcomes

Primary Outcomes

Not specified

Similar Trials